
Adradac 1.5mg Injection
Marketer
Suncure Lifescience Pvt Ltd
Salt Composition
Edaravone (1.5mg)
Overview Adradac 1.5mg Injection
Edaravone 1.5mg injection combats the debilitating effects of amyotrophic lateral sclerosis (ALS), a neurodegenerative condition causing muscle weakness and functional impairment. This antioxidant medication mitigates nerve cell damage, potentially slowing disease advancement. Administered intravenously by a healthcare professional, it's reserved for situations where oral intake is infeasible. Follow your physician's prescribed dosage and schedule meticulously; if a dose is missed, administer it promptly upon recollection. Commonly reported adverse effects include headache, ecchymosis, and gait abnormalities. Injection site reactions, such as pain, erythema, or edema, are possible but typically transient. Persistent or bothersome side effects warrant medical consultation. Report any allergic symptoms, including pruritus, lip, tongue, or facial swelling, immediately as they necessitate prompt medical intervention.
Uses of Adradac 1.5mg Injection
Lou Gehrig's disease
Major Benefits of Adradac 1.5mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Adradac 1.5mg Injection:
- Bruise
- Walking difficulties
- Headache
- Injection site reactions (pain, swelling, redness)
How to use Adradac 1.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Adradac 1.5mg Injection works:
Adradac 1.5mg Injection offers antioxidant, neuroprotective, and nootropic benefits. Its mechanism involves mitigating nerve damage from free radical attack, thus retarding amyotrophic lateral sclerosis (ALS) symptom advancement. This effect stems from its ability to restore equilibrium between antioxidants and free radicals, reducing oxidative stress within the brain.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Adradac 1.5mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Adradac 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Adradac 1.5mg Injection while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Adradac 1.5mg Injection's impact on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Adradac 1.5mg Injection administration to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Adradac 1.5mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Data regarding Adradac 1.5mg Injection use in such patients is limited. Dosage alteration is not advised for those with mild to moderate liver dysfunction.
What if you forget to take Adradac 1.5mg Injection :
NA
Facts to Know About Adradac 1.5mg Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrazolone Derivatives |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) |
| Actions | Cognitive enhancer |
